A prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the recombinant zoster vaccine in Chinese adults ≥50 years of age by Xinghuo Pang, O’Mareen Spence, Neeraj Parmar, Jing Wang, Tao Zhou, Xiang Guo, Audrey Colliou, Sheela Pradeep Sarang, Mitra Yousefi, Huifeng Yun

Get full text

Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States by Ana Florea, Lina Sy, Lei Qian, Bradley Ackerson, Yi Luo, Jun Wu, Yanjun Cheng, Jennifer Ku, Leticia Vega Daily, Harpreet Takhar, Jeannie Song, Elizabeth Chmielewski-Yee, O’Mareen Spence, Harry Seifert, Driss Oraichi, Hung Fu Tseng

Get full text

Effectiveness and safety of the recombinant zoster vaccine in adult patients with systemic lupus erythematosus: a claims-based retrospective cohort study in the USA by Alexis Ogdie, Michael D George, Huifeng Yun, Kristin Palmsten, Omar Ali, Cheryl N McMahill-Walraven, Aziza Jamal-Allial, Mano Selvan, Djeneba Audrey Djibo, Driss Oraichi, Sophie E Mayer, Sheryl A Kluberg, O’Mareen Spence, Harry Seifert, Andrew L Simon, Jenice S Ko, Caroline Hugh, Meg Her, Kathleen Shattuck, Kimberly Daniels, Qianli Ma, Rachel P Ogilvie, Najat Ziyadeh

Get full text